Ocugen, Inc. (OCGN) Q2 2026 Earnings Call Transcript
AI Summary
Ocugen, Inc. presented its Q2 2026 earnings call transcript, focusing on its financial outcomes and pharmaceutical advancements. The company's performance is significant for biotech investors and healthcare markets.